These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 14039100)

  • 1. Clinical evaluation of 4-propylamino-1H-pyrazolo [3,4-d]pyrimidine (NSC-4928).
    SCOTT JL; FOYE LV
    Cancer Chemother Rep; 1962 Jul; 20():73-80. PubMed ID: 14039100
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of pyrazole-pyrimidine preparation (Ciba 24:650-Ba) on anginose pain].
    BUZZI A; BOVERINI A; LISSARRAGUE V
    Dia Med; 1962 Jun; 34():1128-30. PubMed ID: 13875272
    [No Abstract]   [Full Text] [Related]  

  • 3. [Present status of anticancer chemotherapy. III. The pyrimidines, N-desacetylthiocolchicine].
    RAVINA A; ELOY P
    Presse Med (1893); 1961 Mar; 69():587-90. PubMed ID: 13739897
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results obtained with DG 428 in clinical cancerology].
    IZARN P; EMBERGER JM; GARY-BOBO J
    Montp Med; 1960 Nov; 58():156-64. PubMed ID: 13718404
    [No Abstract]   [Full Text] [Related]  

  • 5. [Note on the use of 2-(2-cholorobenzylthi)-4-dimethylamino-5-methylpyrimidine HC1 in anti-cancer chemotherapy].
    FAUVET J; BRULE G; BOIRON M
    Bull Assoc Fr Etud Cancer; 1959; 46():792-7. PubMed ID: 13821752
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and biological evaluation of some novel pyrazolopyrimidines incorporating a benzothiazole ring system.
    Azam MA; Dharanya L; Mehta CC; Sachdeva S
    Acta Pharm; 2013 Mar; 63(1):19-30. PubMed ID: 23482310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytostatic treatment of bladder tumors. First experiences with the new cytostatic agent DG 428].
    DEWULF L; VAN STEENBRUGGE F; VAN VAERENBERGH PM
    Belg Tijdschr Geneesk; 1960 Jun; 16():590-600. PubMed ID: 13816337
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the treatment of malignant tumors in the gynecological field and of breast cancer with cytostatics].
    FRANZ G; HEYN G
    Geburtshilfe Frauenheilkd; 1962 Jan; 22():25-36. PubMed ID: 13894716
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis, anticancer and radioprotective activities of some new pyrazolo[3,4-d]pyrimidines containing amino acid moieties.
    Ghorab MM; Ragab FA; Noaman E; Heiba HI; Aboulmagd SA
    Arzneimittelforschung; 2009; 59(2):96-103. PubMed ID: 19338140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anhydrous versus hydrated N4-substituted 1H-pyrazolo[3,4-d]pyrimidine-4,6-diamines: hydrogen bonding in two and three dimensions.
    Trilleras J; Quiroga J; Cobo J; Marchal A; Nogueras M; Low JN; Glidewell C
    Acta Crystallogr B; 2008 Oct; 64(Pt 5):610-22. PubMed ID: 18799849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of pyrazolo[4,3-d]pyrimidine analogues.
    Yuan L; Song C; Li C; Li Y; Dong L; Yin S
    Eur J Med Chem; 2013 Sep; 67():152-7. PubMed ID: 23851116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of novel pyrazolo[3,4-d]pyrimidine derivatives as potential anti-breast cancer agents.
    Abd El Hamid MK; Mihovilovic MD; El-Nassan HB
    Eur J Med Chem; 2012 Nov; 57():323-8. PubMed ID: 23085106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines.
    Traxler P; Bold G; Frei J; Lang M; Lydon N; Mett H; Buchdunger E; Meyer T; Mueller M; Furet P
    J Med Chem; 1997 Oct; 40(22):3601-16. PubMed ID: 9357527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.
    El-Sayed Ali T
    Eur J Med Chem; 2009 Nov; 44(11):4385-92. PubMed ID: 19586688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some pyrazole and pyrazolo[3,4-d]pyrimidine derivatives: synthesis and anticancer evaluation.
    Shamroukh AH; Rashad AE; Abdel-Megeid RE; Ali HS; Ali MM
    Arch Pharm (Weinheim); 2014 Aug; 347(8):559-65. PubMed ID: 24801813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line.
    Schenone S; Bruno O; Bondavalli F; Ranise A; Mosti L; Menozzi G; Fossa P; Donnini S; Santoro A; Ziche M; Manetti F; Botta M
    Eur J Med Chem; 2004 Nov; 39(11):939-46. PubMed ID: 15501543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancerostatica. I. synthesis of some pyrazolo[1,5-a]pyrimidine and pyrazolo [3,4-b] pyridine derivatives.
    Nantka-Namirski P; Kaczmarek L
    Pol J Pharmacol Pharm; 1978; 30(4):563-8. PubMed ID: 740557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Substituted-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine derivatives: design, synthesis, antitumor and EGFR tyrosine kinase inhibitory activity.
    Abbas SE; Aly EI; Awadallah FM; Mahmoud WR
    Chem Biol Drug Des; 2015 May; 85(5):608-22. PubMed ID: 25318985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship studies of pyrazolo[3,4-d]pyrimidine derivatives leading to the discovery of a novel multikinase inhibitor that potently inhibits FLT3 and VEGFR2 and evaluation of its activity against acute myeloid leukemia in vitro and in vivo.
    Yang LL; Li GB; Ma S; Zou C; Zhou S; Sun QZ; Cheng C; Chen X; Wang LJ; Feng S; Li LL; Yang SY
    J Med Chem; 2013 Feb; 56(4):1641-55. PubMed ID: 23362959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
    Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
    Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.